Discussion
In this study of employees found in a workplace screening to have pre-diabetes, most had engaged in at least one recommended behavior to prevent type 2 diabetes in the 3-month period after the screening. Using both quantitative and qualitative data we also identified key facilitators of and barriers to this engagement. While others studies have examined the relationship between awareness of a pre-diabetes diagnosis and risk-reducing behaviors,1 ,20 ,33 our study is one of the first to describe the frequency of engagement in risk-reducing behaviors to prevent type 2 diabetes among employees found to have pre-diabetes through a workplace screening and to identify key opportunities to optimize their engagement in preventive strategies.
Many more employees we surveyed ∼3 months after they were screened reported engaging in self-directed efforts to lose weight and achieve recommended levels of physical activity than in a community DPP. While the main DPP clinical trial identified specific weight loss and physical activity targets that individuals can aim for to prevent or delay the onset of type 2 diabetes,7 it is unclear whether such individually-directed efforts can be as effective in preventing or delaying the onset of type 2 diabetes as formal programs such as DPPs that offer structured, ongoing support.11 ,34 Although the DPP continues to be disseminated in communities across the USA,9 including southeast Michigan where many of the study participants lived, our interviews revealed that competing demands such as work and family responsibilities often impeded engagement in structured programs inside or outside of the workplace. An alternative approach that could help some busy employees engage in behavior change while still receiving ongoing support would be to encourage them to engage in online versions of the DPP that can be accessed on demand.35
Nearly one in five employees we surveyed had discussed metformin with a primary care provider since the biometric screening. Although we did not ask participants whether they were actually taking metformin for the prevention of type 2 diabetes at follow-up, our results suggest that prompting discussion of metformin with a primary care provider could be a way to spur people with pre-diabetes to be considered for this preventive therapy.
As more Americans with pre-diabetes are likely to be diagnosed through the AMA-CDC Prevent Diabetes STAT initiative14 and the US Preventive Services Task Force's recent broadening of criteria for screening for type 2 diabetes,15 our findings point to several potential opportunities to optimize engagement of these individuals in efforts to reduce their risk for type 2 diabetes. For example, in our surveys we found that engagers had more modest perceptions of their risk for type 2 diabetes than non-engagers. It is possible that more modest risk perceptions—in which there is perhaps a recognition that risk for type 2 diabetes is elevated yet the development of type 2 diabetes is not felt to be a foregone conclusion—could yield less anxiety and thus leave individuals better poised to take preventive actions.18 ,26 ,27 ,36 Alternatively, perceived risk could have been lower among individuals who were engaged in behaviors to prevent type 2 diabetes because they were taking action to reduce their risk. Either way, this finding suggests that different levels and types of perceptions of risk for type 2 diabetes may be closely related to behaviors to prevent type 2 diabetes and should be closely examined in future research.
We also found that engagers had higher levels of motivation—including both greater autonomous and controlled motivation—to prevent type 2 diabetes. Further, the importance of motivation was voiced repeatedly among interviewed respondents. This finding reinforces the critical importance of enhancing motivation to prevent type 2 diabetes as another key ingredient for engagement in evidence-based preventive strategies. Future research should focus on testing promising strategies to bolster levels of motivation to prevent type 2 diabetes such as motivational interviewing,37 tailored messaging,38 peer support,39 financial incentives, and different combinations of these approaches.40 Since autonomous motivation is more likely to produce long-term, sustained behavior change than controlled motivation,30 it will be important to track the degree to which such intervention strategies affect different types of motivation to prevent type 2 diabetes and whether those with higher levels of autonomous motivation indeed sustain healthy behaviors to a greater degree than those with controlled motivation.
Another important difference between engagers and non-engagers was their level of patient activation, which refers to individuals' overall understanding of their roles in healthcare processes, as well as having the knowledge, skills, and confidence to manage their own health.41 In this case, individuals who were more activated prior to the screening may have been better able to translate information about pre-diabetes into engagement in preventive strategies. Alternatively, information about pre-diabetes may have preferentially boosted activation in some individuals, thus leading them to engage in preventive strategies. Though we are unable to determine which of these dynamics occurred in our study, both potential explanations suggest patient activation may play an important role in facilitating engagement in recommended behaviors to prevent type 2 diabetes and thus should be examined in future research.
Key facilitators of engagement that emerged in our interviews included assistance and encouragement from social networks42 as well as use of external supports such as tracking devices. Important barriers to engagement included competing demands and insufficient resources for healthy behaviors. These factors could be leveraged either alone or in combination in the design of approaches to promote engagement in behaviors to prevent type 2 diabetes. Some examples of approaches suggested by our findings include sharing information about pre-diabetes with key members of an individual's social network,43 providing ready access to devices to track weight, food intake and physical activity,44 building competence and self-efficacy to integrate preventive behaviors into busy schedules,45 and/or enhancing access to affordable, nutritious foods and exercise opportunities.46
Additionally, both engagers and non-engagers identified social support and external tools as key facilitators of engagement, and competing demands and low motivation as important barriers to engagement. More research is needed to understand the factors that enable engagers to successfully capitalize on these shared facilitators and overcome these shared barriers so that these factors can be taken into account in the design of interventions to promote engagement in behaviors to prevent type 2 diabetes.
Limitations
Our data rely on participant self-report and focus only on engagement in preventive strategies ∼3 months after a workplace screening. Our sample may not be representative of other populations, particularly those with lower incomes or less education. Although the StayWell health coaches invited study participation from all employees found to have pre-diabetes, and key demographic characteristics of study participants and all employees found to have pre-diabetes in the screening were similar, employees who were already engaged in behaviors to prevent type 2 diabetes could have been more likely to participate in the study. Further, because of our study design we were unable to determine whether postscreening engagement in recommended behaviors was a direct result of the screening. We did not inquire about participants' BMI and were unable to measure how successful individuals who were trying to lose weight had been (ie, how much progress they had made towards losing 7% of their body weight as recommended). We measured physical activity through a widely used survey scale, which may be less valid and reliable than objective measures of physical activity. Finally, we were unable to link our survey and interview data to other biometric screening and HRA data that had been collected during the workplace screening.
In conclusion, most employees with pre-diabetes who we surveyed had engaged in at least one recommended strategy to prevent type 2 diabetes ∼3 months after they had been found to have pre-diabetes during a workplace screening. Further, we identified key facilitators of and barriers to engagement in recommended preventive behaviors. More research is needed to understand employees' reactions to and understanding of a pre-diabetes diagnosis, measure longer-term engagement in preventive behaviors among employees with pre-diabetes, and test promising strategies to optimize their ongoing engagement in strategies to delay or prevent the onset of type 2 diabetes.